Impax Asset Management Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.39M | Buy |
10,234
+445
| +5% | +$250K | 0.04% | 220 |
|
|
2026
Q1 | $5.5M | Buy |
9,789
+1,143
| +13% | +$733K | 0.04% | 206 |
|
|
2025
Q4 | $5.85M | Hold |
8,646
| – | – | 0.04% | 195 |
|
|
2025
Q3 | $5.52M | Sell |
8,646
-207
| -2% | -$126K | 0.03% | 190 |
|
|
2025
Q2 | $4.75M | Hold |
8,853
| – | – | 0.03% | 210 |
|
|
2025
Q1 | $3.72M | Buy |
8,853
+304
| +4% | +$132K | 0.02% | 216 |
|
|
2024
Q4 | $3.53M | Sell |
8,549
-106
| -1% | -$46.5K | 0.02% | 230 |
|
|
2024
Q3 | $4.37M | Buy |
8,655
+1,110
| +15% | +$539K | 0.02% | 226 |
|
|
2024
Q2 | $3.68M | Buy |
7,545
+5,800
| +332% | +$2.91M | 0.02% | 225 |
|
|
2024
Q1 | $942K | Hold |
1,745
| – | – | ﹤0.01% | 266 |
|
|
2023
Q4 | $969K | Buy |
1,745
+700
| +67% | +$329K | ﹤0.01% | 283 |
|
|
2023
Q3 | $457K | Sell |
1,045
-19
| -2% | -$9.47K | ﹤0.01% | 346 |
|
|
2023
Q2 | $534K | Hold |
1,064
| – | – | ﹤0.01% | 334 |
|
|
2023
Q1 | $532K | Sell |
1,064
-750
| -41% | -$359K | ﹤0.01% | 325 |
|
|
2022
Q4 | $740K | Sell |
1,814
-110
| -6% | -$42.7K | ﹤0.01% | 285 |
|
|
2022
Q3 | $627K | Buy |
1,924
+1,352
| +236% | +$497K | ﹤0.01% | 304 |
|
|
2022
Q2 | $201K | Hold |
572
| – | – | ﹤0.01% | 385 |
|
|
2022
Q1 | $313K | Sell |
572
-3
| -0.5% | -$1.58K | ﹤0.01% | 370 |
|
|
2021
Q4 | $379K | Sell |
575
-2,807
| -83% | -$1.76M | ﹤0.01% | 358 |
|
|
2021
Q3 | $2.1M | Sell |
3,382
-1
| -0% | -$672 | 0.01% | 246 |
|
|
2021
Q2 | $2.14M | Sell |
3,383
-1
| -0% | -$552 | 0.01% | 237 |
|
|
2021
Q1 | $1.66M | Buy |
3,384
+725
| +27% | +$363K | 0.01% | 253 |
|
|
2020
Q4 | $1.33M | Buy |
2,659
+156
| +6% | +$69.8K | 0.01% | 215 |
|
|
2020
Q3 | $984K | Buy |
2,503
+65
| +3% | +$24K | 0.01% | 219 |
|
|
2020
Q2 | $805K | Sell |
2,438
-60
| -2% | -$17.4K | 0.01% | 228 |
|
|
2020
Q1 | $605K | Buy |
2,498
+312
| +14% | +$81.4K | 0.01% | 231 |
|
|
2019
Q4 | $571K | Buy |
2,186
+160
| +8% | +$42.2K | 0.01% | 236 |
|
|
2019
Q3 | $551K | Buy |
2,026
+186
| +10% | +$51.8K | 0.01% | 223 |
|
|
2019
Q2 | $507K | Buy |
1,840
+460
| +33% | +$113K | 0.01% | 225 |
|
|
2019
Q1 | $309K | Buy |
1,380
+198
| +17% | +$40.9K | ﹤0.01% | 269 |
|
|
2018
Q4 | $220K | Sell |
1,182
-52
| -4% | -$10.7K | ﹤0.01% | 256 |
|
|
2018
Q3 | $308K | Buy |
+1,234
| New | +$300K | ﹤0.01% | 252 |
|
Other funds holding IDXX
Impax Asset Management Group's IDXX Position: Q2 2026 in Review
Impax Asset Management Group increased its Idexx Laboratories (IDXX) stake by 4.5% in Q2 2026, buying an estimated $250K and bringing the position to 10,234 shares worth $5.39M. The position accounts for 0.04% of the portfolio, ranked #220.
Impax Asset Management Group first reported a position in IDXX in Q3 2018 and has held it in 32 quarters since. The position peaked at $5.85M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Impax Asset Management Group held 10,234 shares of Idexx Laboratories worth $5.39M as of Q2 2026.
- Impax Asset Management Group bought 445 Idexx Laboratories shares in Q2 2026, an estimated $250K.
- Idexx Laboratories made up 0.04% of Impax Asset Management Group's portfolio in Q2 2026, its #220 holding.
- Impax Asset Management Group first reported a position in Idexx Laboratories in Q3 2018 and has held it in 32 quarters since.
- Impax Asset Management Group's Idexx Laboratories position peaked at $5.85M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.